About Us
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and the largest sequencing capacity in the world.

Novogene delivers unsurpassed data quality to support our customers’ research goals. We are a world-leader in NGS services, with 2,600 employees and multiple locations across the globe. Novogene has strong scientific expertise and experience with 29 NGS-related patents, as well as over 4920 research papers, including publications in first tiers journals such as Cell, Nature and Science.

A privately-owned institution headquartered in Beijing with branches in Hong Kong China, US, UK, Singapore, Netherlands and Japan, Novogene was founded in 2011 and has been growing rapidly over the past few years. Novogene has genomic sequencing labs in the US (at The University of California at Davis campus), China, Singapore, and the UK (Cambridge).